If you have been watching Timken (TKR) lately, the appointment of Lucian Boldea as CEO and Michael Discenza as CFO probably caught your attention. Boldea arrives from Honeywell with a reputation for steering major automation and innovation initiatives. This could signal a new chapter for the industrial manufacturer. Leadership transitions like these can mark an inflection point for a company, raising questions for investors about whether fresh strategic moves could translate to stronger competitive positioning or financial performance in the future.

Looking at the bigger picture, Timken’s stock has shown volatile momentum over the past year, finishing down 5% even as it bounced 13% so far in 2025 and climbed nearly 12% in the past three months. The changes at the top come just after several other company updates, including the release of a new CSR report and planned appearances at industry conferences. While the market may be recalibrating its outlook amid the executive shakeup, Timken’s long-term returns (up 59% over five years) suggest that investors are balancing short-term uncertainty with belief in the company’s underlying potential.

After this year’s swings and the new leadership team stepping in, the key question is whether Timken’s current valuation represents a real chance to buy in before growth accelerates, or if the market is already pricing in everything ahead.

Most Popular Narrative: 6% Undervalued

According to community narrative, Timken is seen as undervalued by 6% based on analyst forecasts, future earnings, and margin improvements, using a discount rate of 9.0%.

"The company is committed to delivering $75 million in cost savings in 2025. This should counteract inflationary pressures and support margin expansion, positively affecting net margins and earnings. Timken plans to optimize its automotive OEM business portfolio, targeting more than half for potential divestment or restructuring. This focus is expected to enhance corporate margins starting in 2026 and 2027, contributing to overall earnings growth."

Curious how these margin moves and savings targets compare to a price that could be low right now? The analysts behind this narrative anticipate a significant shift in Timken's profitability, and further changes may be in store. Interested in the future metrics that make this company appear undervalued? The details suggest a growth outlook that is not universally anticipated.

Result: Fair Value of $84 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, ongoing tariff impacts and softer industrial demand could challenge Timken's growth outlook. These factors may also put pressure on margins in the near term.

Find out about the key risks to this Timken narrative.

Another View: SWS DCF Model Perspective

Taking a different approach, our DCF model also indicates Timken is undervalued compared to its current share price. However, it is worth considering whether the DCF captures risks that multiples might miss, or if the model is too optimistic.

Look into how the SWS DCF model arrives at its fair value.

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day ( check out Timken for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover undervalued stocks based on their cash flows. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Build Your Own Timken Narrative

If you have a different perspective or want to test your own assumptions, you can build a personalized view of Timken’s future in just a few minutes. do it your way.

A great starting point for your Timken research is our analysis highlighting 4 key rewards and 1 important warning sign that could impact your investment decision.

Looking for More Smart Investment Opportunities?

Don't stop your research with Timken. Make your next move by checking out unique investment ideas you might be missing. Uncover new strategies and fresh stocks that could give your portfolio that extra edge. These are opportunities that savvy investors spot early.

• Tap into the future of healthcare by targeting the medical innovators powering breakthroughs with healthcare AI stocks.
• Boost your portfolio's income with companies offering robust returns through dividend stocks with yields > 3%.
• Seize untapped value by searching for high-potential opportunities with undervalued stocks based on cash flows.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.